Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Vaccines and Molecular Therapeutics

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1622122

Identification of novel genetic biomarkers for ChAdOx1 nCoV-19 mediated immunogenicity

Provisionally accepted
Wan-Hsuan  ChouWan-Hsuan Chou1Che-Mai  ChangChe-Mai Chang1Jafit  TingJafit Ting1Min-Rou  LinMin-Rou Lin1Hsin-Ni  LiaoHsin-Ni Liao1Yi-Chien  ChouYi-Chien Chou1Chun-Yu  WeiChun-Yu Wei1Hsin-Hui  ChiHsin-Hui Chi1Szu-Ying  HoSzu-Ying Ho1Wei-Tzu  LuoWei-Tzu Luo1Cheng-Lin  TsaiCheng-Lin Tsai1Ching-Hsuan  ChaoChing-Hsuan Chao1Lu-Chun  ChenLu-Chun Chen1Tsung-Hsun  WuTsung-Hsun Wu1Wei-Chih  LiuWei-Chih Liu1Quynh Anh  NguyenQuynh Anh Nguyen1Hui-Wen  ChangHui-Wen Chang1Ching-Sheng  HungChing-Sheng Hung2Shiao-Ya  HongShiao-Ya Hong3Jude  Chu-Chun WangJude Chu-Chun Wang4Shih-Hsin  HsiaoShih-Hsin Hsiao1*Wei-Chiao  ChangWei-Chiao Chang1*
  • 1Taipei Medical University, Taipei, Taiwan
  • 2Wan Fang Hospital, Taipei, Taiwan
  • 3National Yang Ming Chiao Tung University, Taipei, Taiwan
  • 4Taipei Medical University Hospital, Taipei, Taiwan

The final, formatted version of the article will be published soon.

Research comprehensively examining factors for COVID-19 DNA vaccine responses is lacking, particularly in Asian populations. This study aims to investigate biomarkers of reactogenic and immunogenic responses after DNA-based COVID-19 vaccination in a Taiwan population.A genome-wide association study (GWAS) of 415 Taiwanese healthcare workers was conducted to identify genetic variants associated with reactogenic and immunogenic responses to the first and second doses of ChAdOx1 nCoV-19 vaccine. Furthermore, gene set enrichment analysis was conducted to elucidate the underlying biological pathways. Finally, a polygenic score (PGS) was utilized to assess the synergistic host effects on neutralizing antibody (NT50).We identified 501 suggestive significant genetic associations with vaccine responses, enriched in lipid and lipophilic vitamin metabolism, interleukin signaling, and neurotransmitter release pathways. Moreover, we observed a combined effect of genetics with age and sex on NT50 after the second dose. Notably, the negative correlation between age and NT50 was stronger in lower PGS groups (ρlowPGS = -0.5 , ρmediumPGS = -0.2 , ρhighPGS = -0.0072).Our study fills a critical gap by addressing the lack of research on genetic factors of ChAdOx1 nCoV-19 vaccine responses in Asian population, providing valuable insights into the genetic basis of DNA-based vaccine responses. The synergic host effect highlights the value of integrating genetic information with other host factors as a biomarker to predict individual vaccine responses. Our findings can contribute to personalized vaccination strategies and future vaccination policies.

Keywords: polygenic effect, host factors, COVID-19 vaccine responses, Genomics, biomarker

Received: 02 May 2025; Accepted: 02 Sep 2025.

Copyright: © 2025 Chou, Chang, Ting, Lin, Liao, Chou, Wei, Chi, Ho, Luo, Tsai, Chao, Chen, Wu, Liu, Nguyen, Chang, Hung, Hong, Wang, Hsiao and Chang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Shih-Hsin Hsiao, Taipei Medical University, Taipei, Taiwan
Wei-Chiao Chang, Taipei Medical University, Taipei, Taiwan

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.